In MLL-AF4 B-cell acute lymphoblastic leukemia (ALL or B-ALL), the expression of the PROM1 gene encoding a specific marker (CD133) is regulated by MLL-AF4 and has proven to be a good target for the treatment of MLL-r leukemia [274,275]. The gene discussed is KMT2A; the disease is leukemia.